Skip to main content

and
  1. Article

    Open Access

    Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington’s disease models

    Small interfering RNAs are a new class of drugs, exhibiting sequence-driven, potent, and sustained silencing of gene expression in vivo. We recently demonstrated that siRNA chemical architectures can be optimi...

    Faith Conroy, Rachael Miller, Julia F. Alterman in Nature Communications (2022)

  2. No Access

    Article

    A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system

    Sustained silencing of gene expression throughout the brain using small interfering RNAs (siRNAs) has not been achieved. Here we describe an siRNA architecture, divalent siRNA (di-siRNA), that supports potent,...

    Julia F. Alterman, Bruno M. D. C. Godinho, Matthew R. Hassler in Nature Biotechnology (2019)